Trial Bolsters Three Drug Combination Treatment as Standard After First Multiple Myeloma Relapse

A new trial confirms the effectiveness of pomalidomide in treating lenalidomide resistant multiple myeloma

Published Jun 7, 2019

NOW
PLAYING
Advancements In FLT3 Inhibitors: New Drugs For Acute Myeloid Leukemia (AML)
NOW
PLAYING
Acute Myeloid Leukemia (AML): Treatment Options After Relapse
NOW
PLAYING
Acute Myeloid Leukemia: Making Treatment Decisions
NOW
PLAYING
The Promise of CAR T-Cell Therapy for Multiple Myeloma
NOW
PLAYING
'The Google Earth of Endometrial Cancer' -- a New, Molecular Snapshot Could Lead to Better Treatment of the Disease
NOW
PLAYING
A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.